4P-Pharma is a recognized actor in the ADHD pipeline drug development.

Stimulant abuse and addiction is a major global health problem and prescription drugs are indeed more and more abused, in virtue of their “rewarding” psychotropic effects.  ADHD medications abuse increased by 4 fold, and led to a 400% increased in emergency room visits from 2006 to 2014.  4P-003 is our innovative product developed as a novel deterrent approach for stimulant misuse, under a 505(b)2 approval.